US20080108971A1 - Infiltration cannula - Google Patents

Abstract

An infiltration cannula and method of using the infiltration cannula during an infiltration procedure are disclosed herein. The infiltration cannula has a flexible cannula and a hub. The cannula has a proximal end and a distal end. The cannula also has a plurality of apertures disposed in a pattern about the distal end. The apertures are configured to infiltrate fluid into the subcutaneous or muscle tissue of a patient. The hub is configured to be held by a person performing the infiltration procedure. The hub has a first end and an opposing second end. The first end is attached to the proximal end of the flexible cannula and the second end includes a connector configured to connect to an input source for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient. The fluid flows from the connector, through the hub and into the cannula.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
• The present application is a divisional application of U.S. application Ser. No. 10/877,566, filed on Jun. 25, 2004 which is a continuation-in-part application of U.S. patent application Ser. No. 10/442,370, filed on May 21, 2003 and is related to pending application Ser. No. 10/877,337, filed on Jun. 25, 2004, the disclosures of which are expressly incorporated herein by reference.
STATEMENT REFederally Sponsored Research/Development
• Not Applicable
BACKGROUND OF THE INVENTIONDefinitions
• Tumescent Technique The tumescent technique is a method of subcutaneous drug delivery of large volumes of very dilute medication together with dilute epinephrine in isotonic solution of crystalloid infiltrated directly into subcutaneous fat or muscle to produce swelling and firmness, or tumescence, of the targeted tissues, and thus produce very slow systemic absorption as a result of intense subcutaneous vasoconstriction.
• Tumescent Drug Delivery: Tumescent drug delivery refers to the tumescent technique for delivering a drug into the subcutaneous space. Drugs other than lidocaine can be administered by means of tumescent delivery, that is, by subcutaneous infiltration of extremely dilute drug, with or without epinephrine as a vasoconstrictor.
• Tumescent Local Anesthesia (TLA) is local anesthesia produced by direct infiltration into subcutaneous tissue of large volumes of very dilute lidocaine and epinephrine in a crystaloid solution such as physiologic saline (NaCl) or lactated Ringer's solution.
• Tumescent Local Anesthetic Solution (TLA Solution) is the local anesthetic solution used to produce TLA. Typically, a TLA Solution consists of a 10 to 20 fold dilution of commercially available concentration of lidocaine and epinephrine. Thus, a commercial solution of lidocaine and epinephrine contains 10 grams of lidocaine per liter (10 gm/L) and 10 milligrams of epinephrine per liter. In contrast TLA Solution typically contains less than 1 gm/L lidocaine and epinephrine (1 mg/L). Typically the volume of infiltrated TLA Solution is so large that the skin and subcutaneous tissue becomes tumescent, in other words swollen and firm.
• The present invention relates in general to cannulas and in particular to an infiltration cannula that allows for intermittent infiltration of fluids, such as a local anesthetic.
• Many medical procedures require infiltration of fluids, such as a local anesthetic. One method of infiltration of local anesthetic is via an infiltration cannula. Infiltrators are known as sprinkler-tip or Klein™ (the present applicant) needle infiltrators. These cannulas are constructed out of a rigid stainless steel and have one or more apertures, which are typically round or oval, and are distributed about the distal end of the cannula. The apertures are distributed over about 15% to 25% or less than 5.0 cm. of the distal end of the cannula needle. These traditional infiltration cannulas are intended to be inserted through a small incision in the patient's skin and then moved in and out through the subcutaneous tissue while a dilute solution of local anesthetic (or other pharmaceutical solution) is ejected through the distal apertures. Such infiltrators typically have a blunt tip and require the placement of a small hole (made by a one mm skin-biopsy punch or a small surgical blade) through which the blunt tipped cannula can be passed. The piston-like in and out motion of the cannula causes the patient discomfort.
• Another method of fluid insertion is via a peripherally inserted central catheter, also called a PICC line comprising an elongate plastic tube that is placed inside a vein of the patient. PICC lines are typically used for procedures requiring delivery of fluids over a prolonged period of time. For example, a PICC line may be used when a patient needs to receive intravenous (IV) fluids, such as medication or nutrients over a prolonged period of time, such as a week or more.
• The On-Q® Pain Management System marketed by I-Flow® Corporation employs a PICC line type system for continuously providing local anesthetic. This system provides prolonged local anesthesia by means of an elastomer (elastic container) device that continuously infiltrates a solution of local anesthesia over many hours. The On-Q® device comprises a long soft flexible tube with many small holes arranged along a significant portion of the tube. The On-Q® device is designed to be initially positioned within a surgical wound at the time of surgery. After the surgical wound is closed, the On-Q® device permits slow steady infiltration of a local anesthetic solution into the wound, thereby attenuating post-operative pain. The On-Q® device cannot be inserted through a tiny hole in the skin into subcutaneous tissue. Thus there is a need for a simple device that can permit the direct percutaneous insertion of a multi-holed infiltration cannula into subcutaneous tissue for the localized delivery of medications such as local anesthetics, chemotherapeutic agents, or crystalloids for parenteral hydration.
• Traditional techniques for subcutaneous injection of local anesthetic solutions use a high-concentration/low-volume of local anesthetic. This is associated with a rapid systemic absorption of the local anesthetic. In order to achieve a prolonged local anesthetic effect, the traditional techniques for using local anesthetics necessitate either frequent repeated injections or slow continuous subcutaneous infusion of the local anesthetic. As described above, repeated injections or piston-like movement of the cannula causes patient discomfort. Slow continuous infiltration may not be desirable in certain situations. Furthermore, continuous infiltrations restrict patient movement for extended periods of time which also cause the patient discomfort. Thus, there is a need for a system for infiltration of a local anesthetic into subcutaneous tissue which decreases patient discomfort, and allows prolonged local anesthesia either by rapid bolus injections or continuous slow infiltration. Furthermore there is a need for a devise that can provide pre-emptive local anesthesia before a surgical wound is created. There is also a need for a percutaneously-insertable infiltration cannula, with applications that are unrelated to the delivery of local anesthesia, which can be easily inserted by rescuers with minimal clinical skill or training. One example is the need for a cannula that permits emergency fluid resuscitation in situations where an IV cannot be established such as nighttime military combat conditions where using a flash light to establish an IV access would be extremely dangerous. Another example is the need to provide emergency fluid resuscitation to large numbers of patients in acute epidemic diarrhea (dehydration) associated with biological warfare, or mass-trauma situations such as a natural disaster (earth quake) or terrorist attack. There is also a need for a device that can easily provide localized fluid resuscitation to burn victims whereby fluid is infiltrated into the subcutaneous tissue directly subjacent to burned skin.
BRIEF SUMMARY OF THE INVENTION
• The present invention comprises an infiltration cannula and method of using the infiltration cannula during an infiltration procedure. The infiltration cannula preferably includes: a flexible cannula, a hub, and a rigid stylet. The flexible cannula has a proximal end and a distal end. The flexible cannula also has a plurality of apertures disposed in a pattern about the distal end. The apertures are configured to infiltrate fluid into the subcutaneous tissue of a patient. The hub is configured to be held by a person performing the infiltration procedure. The hub has a first end and an opposing second end. The first end is attached to the proximal end of the flexible cannula and the second end includes a connector configured to connect to an input source for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient. The fluid flows from the connector, through the hub and into the flexible cannula.
• The flexile cannula may be manufactured of plastic and the rigid stylet may be fabricated from stainless metal or rigid plastic. The distal end of the cannula is closed to cover the tip of the rigid stylet or open with a hole allowing the tip of the rigid stylet to protrude through. The tip of the rigid stylet is either sharp to directly insert through the skin of the patient, or so blunt that a skin incision is required to permit insertion of the rigid stylet and the cannula into the subcutaneous space. The stylet may be formed to have either a solid or hollow cross-sectional configuration.
• The apertures may be arranged in a helical pattern or in a spiral pattern.
• The apertures may be distributed over about 33% to about 90% of the distal end of the tubular needle.
• The apertures may be round or oval. The size of the apertures need not necessarily be equal.
• The fluid may comprise a local anesthetic or any other therapeutic solution.
• The infiltration procedure may be performed in conjunction with conventional medical procedures such as liposuction, but additionally may simply be used as a mode of systemic drug delivery, or systemic fluid replacement therapy.
• A method of infiltrating fluid into subcutaneous tissue of a patient using an infiltration cannula, such as the one described above may include the following steps.
• A rigid stylet is inserted through a flexible infiltration cannula. The infiltration cannula is inserted through a patient's skin and into the subcutaneous tissue or muscle tissue of the patient at a desired site with the stylet serving as a guiding wire. After the stylet let is withdrawn from the cannula, a fluid is provided from a fluid source via the connector. The fluid is transported from the connector through the hub and into the flexible cannula. The fluid is ejected from the cannula into the subcutaneous tissue or muscle of the patient via the apertures.
• The infiltration cannula used in performing the method preferably includes a connector for receiving the fluid from a fluid source, a hub in communication with the connector and a flexible cannula in communication with the hub. The tubular needle has a plurality of apertures disposed in a pattern about a distal end. The apertures are configured to infiltrate the fluid into the subcutaneous tissue or muscle of the patient.
• The above steps may be repeated intermittently, at intervals between a few minutes to many hours.
• After the desired amount of fluid has been infiltrated at a given site, the infiltration cannula may be removed or may remain in place for possible additional infiltration.
• The infiltration cannula may additionally be inserted at a new site.
• Multiple infiltration cannulas (e.g., two) may be used simultaneously. Use of multiple infiltration cannulas prevents disruption of the infiltration process when one infiltration cannula is removed. Multiple infiltrators can be simultaneously inserted into separate areas to facilitate more rapid delivery of fluids.
BRIEF DESCRIPTION OF THE DRAWINGS
• These as well as other features of the present invention will become more apparent upon reference to the drawings wherein:
• FIG. 1 is a side elevation view of a stainless steel infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section;
• FIG. 2 is a section view of the infiltration cannula shown inFIG. 1;
• FIG. 3 is a side elevation view of a plastic infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section;
• FIG. 4 is an exploded view of the infiltration cannula shown inFIG. 3;
• FIG. 5 is a flow diagram illustrating an exemplary procedure for using an infiltration cannula such as the one shown inFIG. 1 or the one shown inFIG. 3;
• FIG. 6 is an exploded side elevation view of a plastic infiltration cannula through which a blunt-tipped stylet can be inserted; and
• FIG. 7 is a side view of a sharp-tipped stylet insertable through the plastic infiltration cannula ofFIG. 6.
DETAILED DESCRIPTION OF THE INVENTION
• As described in further detail below, the present invention takes advantage of the tumescent technique in order to provide intermittent or continuous, brief or prolonged infiltration of local anesthetic, physiologic fluid, antibiotics or other therapeutic solution. The present invention results in a significant decrease in patient discomfort due to the elimination of the piston-like in and out motion of the cannula. Once the cannula is positioned in place, there is no need to repeatedly move the cannula in and out through the tissue in order to deliver the fluid to a wide area. Using the tumescent technique and stainless steel versions of the present invention, the time needed in order to complete the infiltration of a targeted anatomic area is reduced to nearly half of the time required when using traditional prior art cannulas. The device and method of the present invention can use multiple (e.g., two or more) infiltration cannulas simultaneously. While one cannula is actively dispersing tumescent fluid into the subcutaneous tissue, the surgeon can reposition a second infiltration cannula. This allows the infiltration process to proceed without interruption, whereas prior art techniques of infiltration must be ceased each time the cannula is withdrawn from the skin and re-inserted into another direction.
• The flexible cannula version of the present invention provides a means for relatively rapid fluid resuscitation in emergency situations such as when establishing an intravenous (IV) access is not feasible. The flexible cannula may have important applications as in treating a wounded soldier in night-time combat conditions when establishing an IV access in total darkness is nearly impossible or using a flash light might attract enemy fire. The flexible cannula may similarly have important applications in other areas of use such as treating mass-casualty victims suffering hypovolemia as a result of epidemic infections, biologic warfare, or trauma such as explosions, burns or radiation exposure. The flexible cannula similarly has applications in surgical patients wherein the surgeon can provide localized pre-operative preemptive analgesia and simultaneously provide tumescent delivery of a prophylactic dose of an antibiotic aimed precisely at tissues targeted for surgical intervention.
• As is well known, the tumescent technique was discovered by Jeffrey Alan Klein, M.D. (the present applicant) in 1985. Dr. Klein first published a description of the tumescent technique in 1987 when he described the use of dilute lidocaine and epinephrine to permit liposuction totally by local anesthesia. The technique for tumescent local anesthesia is well known in dermatologic and plastic surgery literature. A detailed description of the tumescent technique has not been published in anesthesiology literature, and therefore, the unique benefits of the tumescent technique are not well recognized by anesthesiologists.
• The tumescent technique comprises a drug delivery system that takes advantage of a recently discovered reservoir effect of injecting a relatively large volume of relatively dilute solution of a drug into the subcutaneous tissue.
• The present invention takes advantage of the tumescent reservoir phenomenon for one of its important applications. After a large volume of fluid containing dilute epinephrine is injected into subcutaneous tissue, the epinephrine-induced vasoconstriction dramatically slows the systemic absorption of the fluid. In effect, this large volume of subcutaneous fluid behaves in a fashion that is analogous to the behavior of a slow-release tablet in the stomach after oral ingestion. Although there is a relatively large total amount of drug in the patients body, the drug is isolated from the systemic circulation by the fact that only the drug on the outer boundary of the mass of drug is the available for absorption, whereas the portion of the drug located within the central portion of the mass of fluid is virtually isolated from the systemic circulation by virtue of profound capillary vasoconstriction. In contrast, when the tumescent fluid does not contain epinephrine there is no clinically significant vasoconstriction after tumescent infiltration, and the tumescent fluid is absorbed relatively rapidly. This has important clinical applications in situations where patients are hypovolemic or dehydrated and unable to be given fluids by mouth or intravenously. The tumescent technique permits rapid systemic hydration by direct subcutaneous or intramuscular injection of a large volume of fluid through a multi-fenestrated infiltration cannula described in this invention.
• There is a prior art technique known as hypodermoclysis wherein a fluid is slowly and continuously infiltrated subcutaneously using a type of steel hypodermic needle, known as a butterfly needle, having a single distal aperture in order to provide fluid to patients who cannot be given fluids by mouth and for whom an IV access cannot be established. Typically hypodermoclysis is used in the treatment of infants, or cancer patients, in which IV access is not easily achieved. The technique of hypodermoclysis is typically used to deliver relatively small volumes of fluid, for example an adult might receive 70 ml per hour. At this small hourly volume hypodermoclysis is not an efficient method for the rapid systemic delivery of fluid in emergency situations that might require two to four liters per hour. The reason is that when using a cannula with only a single distal aperture, the local interstitial fluid pressure increases rapidly immediately adjacent to the single aperture as fluid infiltrates locally, which in turn dramatically slows the rate of subsequent fluid flow into the area. In contrast, the multiple apertures formed along the length of the cannula as described in the present invention, distribute the fluid throughout a much larger volume tissue before there can be a sufficient increase in the interstitial fluid to decrease the rate of additional infiltration. Further more, it is common practice to infiltrate the tumescent fluid into the subcutaneous space under augmented external pressure provided by an external peristaltic pump specifically designed for tumescent infiltration. By way of example and not limitation, a preferred suitable peristaltic infiltration pump is described in pending U.S. patent application Ser. No. 10/811,733, filed Mar. 29, 2004, entitled INFILTRATION PUMP HAVING INSULATED ROLLERS AND PROGRAMMABLE FOOT PEDAL, the disclosure of which is expressly incorporated herein by reference.
• The peristaltic pump provides a sufficient degree of pressure to easily overcome the localized increased interstitial pressure associated with the local effects of a tumescent infiltration. On the other hand, in situations where a peristaltic infiltration pump is not available, such as in remote locations without any available electrical power, the present invention still permits relatively rapid tumescent infiltration by virtue of the multiple holes distributed along the length of the flexible cannula. Furthermore, external hydrostatic pressure can be applied to the fluid flowing into the flexible cannula from the fluid reservoir by means of gravitational force derived from elevating the reservoir one to two meters above the patient. When using gravity to augment the flow of tumescent fluid, the infiltration process can be continuous or intermittent. In exemplary embodiments, the intermittent injections are administered at intervals ranging from every few minutes to eight to twelve hours or more.
• With the tumescent technique for local anesthesia, a large volume of dilute solution of local anesthesia and epinephrine is injected into the subcutaneous space resulting in a large bolus (or reservoir) of solution. The profound vasoconstrictive effect (shrinking of the capillaries) caused by the dilute epinephrine, produces a dramatic delay in the systemic absorption of the local anesthetic, which prolongs the anesthetic effects of tumescent anesthesia for eight to sixteen times longer than traditional techniques.
• Referring now to the drawings wherein the showings are for purposes of illustrating preferred embodiments of the present invention only, and not for purposes of limiting the same,FIGS. 1 and 2 illustrate a stainless steel (reusable)infiltration cannula10 andFIGS. 3-4 and6-7 illustrate a (single use)plastic infiltration cannula30. Thecannula10,30 can be inserted under theskin52 and into thesubcutaneous tissue50 and tumescent local anesthesia can be infiltrated once every eight to twelve hours.
• Stainless steel infiltration cannulas10, such as the one shown inFIGS. 1 and 2, are formed having precision high quality and are preferably reusable. These cannulas can be used to provide tumescent local anesthesia for surgical procedures, such as liposuction, which require tumescent local anesthesia over a relatively large area.
• Thecannula10 includes atubular needle portion12 which has aproximal end14 and adistal end16. Theproximal end14 of thetubular needle12 is attached to ahub20 that is used by the anesthesiologist or surgeon to grasp and hold thecannula10 during the infiltration procedure. Thehub20 is connected to thetubular needle12 at afirst end22 and has aconnector24, such as a luer lock, at an opposing second end. Theconnector24 is connected to a fluid source, such as tubing connected to an IV bag. Fluid enters thecannula10 via theconnector24.
• In exemplary embodiments, the tip at thedistal end16 is closed. The local anesthetic is infiltrated into the patient viaapertures18 located proximate thedistal end16 of thetubular needle12 of thecannula10. In exemplary embodiments, theapertures18 are disposed along thedistal end16 of thecannula10 in a spiral or helical pattern and are distributed over the distal 33% to 90% of thetubular needle12 of thecannula10. For example, if the length of the tubular needle D is 15 cm and theapertures18 at thedistal end16 cover a length d1 of 5 cm, the pattern of apertures of thecannula10 are preferably distributed over 33% of thetubular needle12 of thecannula10.
• Theproximal portion14 of thecannula10 is preferably devoid of apertures in order to prevent fluid from leaking out of the cannula insertion site in the skin.
• Flexibleplastic infiltration cannulas30, such as the one shown inFIGS. 3, 4,6 and7 are single use cannulas and can be used in one of several unique ways. First, an anesthesiologist or surgeon can insert aninfiltration cannula30 withstylet46 into thesubcutaneous tissue50, remove thestylet46, then attach an IV tubing to the infiltrator and inject tumescent local anesthesia into the targeted area without subsequent repositioning of theinfiltration cannula30. The plastic flexible nature of theinfiltration cannula32 of the disposableplastic cannula30 allows the patient to move or change position of the body without risk of injury that might result if a patient moves while a rigid steel cannula is inserted.
• Preferably, thestylet46 is formed of metal, e.g., stainless steel, or of a rigid plastic material. Theplastic cannula30 can be blunt-tipped with themetal stylet tip48 covered by the roundedtip39 of theplastic cannula30. Alternatively, theplastic cannula30 can be open-ended with thestylet46 extending a short distance past theend39 of theplastic cannula30 as shown inFIG. 6. In the case of the open ended cannula, thestylet46 can be either blunt-tipped (seeFIG. 6; requiring a skin incision to permit insertion into the subcutaneous space), or sharp-tipped (seeFIG. 7; permitting the cannula to be inserted directly through the skin and into the subcutaneous space or muscle without requiring a preparatory skin incision). The sharp-tipped stylet can be formed in either a solid or hollow cross-sectional configuration.
• The plastic cannula shown inFIGS. 3 and 4 is similar to an IV catheter except the sharp hollow stylet used for the insertion of an IV catheter can be replaced by a solid obturator/stylet46 that can be either sharp or blunt tipped. Except for theremovable stylet46, theplastic cannula30 is similar to thestainless steel cannula10 shown inFIGS. 1 and 2 and described above. Theplastic cannula30 includes a flexibletubular needle32 having aproximal end34 and adistal end36. The distal end hasapertures38 and theproximal end34 is devoid of apertures. As stated above, in exemplary embodiments, the pattern ofapertures38 in thecannula30 are distributed over the distal 33% to 90% of thetubular needle32 of thecannula30. For example, if thetubular needle32 ofcannula30 shown inFIGS. 3 and 4 has a length D of 15 cm and the pattern of apertures are distributed over a length d1 of 13.5 cm, then theapertures38 are distributed over 90% of the cannula.
• Atypical infiltration cannula10,30 may have a diameter equivalent to 20, 18, 16 or 14 gauge withsmall apertures18,38 placed every 5 mm along the cannula in a spiral or helical pattern. It will be appreciated that the dimensions used herein are exemplary and that the cannula dimensions, range of gauge, length of cannula, relative size shape and pattern of apertures can vary greatly depending upon clinical preference.
• Theproximal end34 of thetubular needle32 shown inFIGS. 3 and 4 is attached to ahub40 that is used by the anesthesiologist or surgeon to hold thecannula30 during the infiltration procedure. Thehub40 is connected to thetubular needle32 at afirst end42 and has aconnector44 at an opposing second end. Theconnector44 is connected to a fluid source. As described above and shown inFIG. 4, thestylet46 can be inserted and removed from thecannula30.
• Infiltration using aplastic infiltration cannula30, such as the one shown inFIGS. 3 and 4, can be accomplished using an infiltration pump. Alternatively, the force of gravity could be used to push the tumescent fluid into the tissues by hanging a reservoir plastic bag of tumescent local anesthesia (or other dilute drug, such as a chemotherapeutic agent or antibiotics) on an IV pole and connecting bag to the infiltration cannula by an IV line.
• Another application is the injection of tumescent local anesthesia into a localized area through which a surgeon plans to make a surgical incision. The effects of vasoconstriction, resulting from the epinephrine in the tumescent local anesthetic solution, within the tumesced tissue minimizes surgical bleeding. In a uniquely preemptive fashion, the present invention can produce, via the pre-operative infiltration of tumescent local anesthesia, prolonged post operative analgesia and also preemptively reduce the risk of surgical wound infections resulting from the bacteriacidal effects of lidocaine.
• Yet another application is to provide an easily accessible route for systemic administration of crystalloid fluids/electrolytes for systemic hydration or for other types of drug therapy. Potential clinical applications include emergency resuscitation with systemic fluids in situations where insertion of an IV catheter into a vein cannot be readily achieved. Examples of situations where emergency access for intravenous delivery of fluids might not be possible include acute trauma or burn wound in civilian or military situations. Another application may be the emergency treatment of dehydration associated with prolonged vomiting or diarrhea as a result of chemical warfare or biological warfare (e.g., epidemic cholera among pediatric patients in rural third world settings). A subcutaneous infiltration catheter can easily be introduced by a layman, whereas inserting an IV catheter into a vein of a patient that is severely dehydrated can be difficult even for a skilled physician. Delivery of systemic fluids by subcutaneous infiltration is safer in a zero gravity situation (for example, the Space Station). The addition of a small amount of capillary vasodilator (e.g., methylnicotinamide) to the subcutaneous fluid can be used to accelerate the systemic absorption of the fluid or drug into the intravascular space. Further applicational uses for the present invention are described in co-pending application serial number unknown, filed concurrently herewith entitled DRUG DELIVERY SYSTEM FOR ACCELLERATED SUBCUTANEOUS ABSORPTION, the disclosure of which is expressly incorporated herein by reference.
• Thecannula10,30 is intended to be inserted far enough through theskin52 so that all of theapertures18,38 are within the fat50 or muscle of the patient. Once thecannula10,30 is properly positioned, it can remain stationary while the local anesthetic (or other pharmaceutical) solution is injected.
• After one portion of the targeted area has been tumesced, the infiltration is briefly terminated (either by turning off the pump or by clamping the IV tubing) while thecannula10,30 is repositioned into another area of the subcutaneous tissue. The infiltration is then restarted with the cannula stationary in its new position.
• Theinfiltrator10,30 can also be used in the traditional mode whereby thecannula10,30 is moved through the targeted tissue while the fluid is simultaneously pumped through thecannula10,30 and into thesubcutaneous tissue50.
• Another unique aspect of the tumescent technique's reservoir effect is that one can conveniently achieve a long, slow, steady absorption of a drug delivered to thesubcutaneous space50 using periodic injections of a tumescent solution. In certain situations, using a slow IV infusion, the alternative technique, can achieve a slow systemic absorption of a drug but may be difficult, require greater clinical expertise, be more expensive, and therefore, less practical than the technique described herein.
• FIG. 5 is a flow diagram illustrating steps performed in an exemplary infiltration procedure using acannula10,30 such as the one shown inFIGS. 1 and 2 or the one shown inFIGS. 3 and 4, respectively. The procedure begins by inserting thetubular needle12,32 of theinfiltration cannula10,30 into a desiredsubcutaneous tissue site50, e.g., via an incision in the patient's skin52 (block100). Fluid is then transported from the fluid source (e.g., an IV bag) into thecannula10,30 via theconnector24,44 that is connected to the fluid source. The fluid is transported from theconnector24,44 through thehub20,40 and into thetubular needle12,32 (block102). The fluid is then ejected from thecannula10,30 into thesubcutaneous tissue50 of the patient via theapertures18,38 at thedistal end16,36 of thetubular needle12,34 of thecannula10,30 (block104).
• The fluid is transported (block102) and ejected (block104) until infiltration at the current site is completed (yes in decision block106). The fluid can be injected into multiple sites in order to distribute the solution over a greater area.
• Infiltration at a particular site may be deemed complete upon emptying of the fluid source or based on the anesthesiologist or surgeon's decision to stop the infiltration at the current site. After one portion of the targeted area has been tumesced, the infiltration can be briefly terminated (either by turning off the pump or by clamping the IV tubing) while thecannula10,30 is repositioned into another area of the subcutaneous tissue. The infiltration may then be restarted with the cannula stationary in its new position. If the infiltration at a site is complete (yes in decision block106), the cannula is removed from the current site (block108). If the infiltration at the current site is not complete (no in decision block106), fluid is transported from the fluid source (block102) and ejected into the subcutaneous tissue (block104) until infiltration at the site is complete (yes in decision block106).
• If infiltration is complete at the current site (yes in decision block106) but infiltration is not complete (no in decision block110), thetubular needle12,32 of theinfiltration cannula10,30 is inserted into a new area ofsubcutaneous tissue50. The process described above is performed until the infiltration process is complete (yes in decision block110). This process can be continuous or repeated intermittently.
• As described above, multiple infiltration cannulas (e.g., can be used at once). Thus, a second or additional cannulas can be inserted (block100) at the same time as a first cannula is being removed (block108). Thus, the infiltration process need not be interrupted in order to reposition a single cannula.
• Additional modifications and improvements of the present invention may also be apparent to those of ordinary skill in the art. Thus, the particular combination of parts described and illustrated herein is intended to represent only a certain embodiment of the present invention, and is not intended to serve as a limitation of alternative devices within the spirit and scope of the invention.

Claims (15)

1. An infiltration cannula for delivering a multi liter amount of fluid to a patient during an infiltration procedure, the infiltration cannula comprising:

a rigid stylet;

a flexible tubular cannula with the rigid stylet disposed within the flexible tubular cannula, the flexible tubular cannula comprising:

a proximal portion;

a distal portion defining a distal end, the distal end being open with a hole, and a tip of the rigid stylet protruding through the hole; and

a plurality of apertures disposed in a pattern about the distal portion, the apertures configured to infiltrate the multi-liter amount of fluid into subcutaneous tissue or muscle of a patient;

a hub configured to be held by a person performing the infiltration procedure, the hub having a first end and an opposing second end, the first end being attached to the proximal portion of the flexible tubular cannula, the second end comprising a connector for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient, the fluid flowing from the connector, through the hub and into the flexible tubular cannula; and

a continuous flow pump connected to the connector of the hub and operative to continuously deliver fluid through the hub and the flexible tubular cannula at least until a large reservoir of fluid is infiltrated into the patient at a desired site of the patient.

2. The infiltration cannula as recited inclaim 1, wherein the tip of the rigid stylet protruding out of the hole is sharp to directly insert the cannula and the stylet through the skin of the patient without a prepatory skin incision.

3. The infiltration cannula as recited inclaim 2, wherein the apertures are distributed over about 33% to about 90% of the distal end of the flexible tubular cannula.

4. The infiltration cannula as recited inclaim 1, wherein the tip of the rigid stylet protruding out of the hole is blunt such that a prepatory skin incision is required to permit insertion of the stylet and flexible tubular cannula through the skin of the patient.

5. The infiltration cannula as recited inclaim 4, wherein the apertures are distributed over about 33% to about 90% of the distal end of the tubular needle.

6. A method of infiltrating a multi-liter amount of fluid into subcutaneous tissue of a patient, the method comprising:

a) inserting a rigid stylet within an open ended flexible tubular cannula until a tip of the rigid stylet protrudes from the open end;

b) inserting the flexible tubular cannula with the rigid stylet disposed therewithin through a patient's skin and into the subcutaneous tissue of the patient at a desired site;

c) removing the stylet from the flexible tubular cannula; and

d) continuously flowing the fluid through the flexible tubular cannula and into the patient via apertures formed along a distal portion of the flexible tubular cannula at least until a large reservoir of fluid has been infiltrated into the patient at the desired site.

7. The method ofclaim 6 wherein the tip of the stylet protruding out of the hole is blunt, and the method further comprises the step of making a prepatory skin incision prior to the inserting the flexible tubular cannula step b).

8. The method ofclaim 6 wherein the tip of the stylet protruding out of the hole is sharp, and the inserting the flexible tubular cannula step b) is accomplished without making a prepatory skin incision.

9. The method recited inclaim 6, further comprising inserting the flexible infiltration cannula at a new site in the patient's skin.

10. The method recited inclaim 6, wherein at least two flexible infiltration cannulas are inserted into the patient's skin to prevent disruption of the method when one flexible infiltration cannula is removed.

11. The method recited inclaim 6, wherein the continuously flowing step includes the step of continuously flowing a local anesthesia fluid.

12. The method recited inclaim 6, wherein the method is performed in conjunction with a surgical procedure or therapeutic drug delivery.

13. The method recited inclaim 6, wherein the apertures formed on the distal portion of the flexible tubular cannula are distributed about 33% to about 90% of the distal portion of the flexible tubular cannula, and the method further comprises the step of positioning the flexible tubular cannula within the patient until all of the apertures are within the patient and maintaining the flexible tubular cannula in the position until at least a portion of the multi-liter amount of fluid is infiltrated into the patient.

14. The cannula as recited inclaim 1, wherein the apertures are arranged in a helical pattern.

15. The cannula as recited inclaim 1, wherein the apertures are arranged in a spiral pattern.

Images